Explore more publications!
Modern Africa Today
Got News to Share?

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on November 3, 2025

EdTalkies Partners with KEPSHA to Champion AI-Powered Competency-Based Learning Across Kenya
November 3, 2025

EdTalkies Partners with KEPSHA to Champion AI-Powered Competency-Based Learning Across Kenya

Indeterminate EIN Presswire
ACASS-OPERATED FALCON 8X COMPLETES MAIDEN FLIGHT TO ANTARCTICA
November 3, 2025

ACASS-OPERATED FALCON 8X COMPLETES MAIDEN FLIGHT TO ANTARCTICA

Indeterminate EIN Presswire
Towing Industry Honors Fallen Tow Operators
November 3, 2025

Towing Industry Honors Fallen Tow Operators

Indeterminate EIN Presswire
Granting of Incentive Stock Options
November 3, 2025

Granting of Incentive Stock Options

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
November 3, 2025

Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025

Indeterminate GlobeNewswire
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
November 3, 2025

Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
PU Prime Launches Black Friday Copy Trading Campaign
November 3, 2025

PU Prime Launches Black Friday Copy Trading Campaign

Indeterminate EIN Presswire
Clinical Study Results on CercaTest RED™ Presented in 18th APCMFM
November 3, 2025

Clinical Study Results on CercaTest RED™ Presented in 18th APCMFM

Indeterminate EIN Presswire
Organogenesis Applauds CMS’s Significant Step In Payment Reform
November 3, 2025

Organogenesis Applauds CMS’s Significant Step In Payment Reform

Indeterminate GlobeNewswire
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 3, 2025

Cellectis to Present a Development Update for eti-cel at ASH 2025

Indeterminate GlobeNewswire
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
November 3, 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

Indeterminate GlobeNewswire
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
November 3, 2025

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

Indeterminate GlobeNewswire
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
November 3, 2025

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
November 3, 2025

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

Indeterminate GlobeNewswire
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting
November 3, 2025

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting
November 3, 2025

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

Indeterminate GlobeNewswire
Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
November 3, 2025

Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
November 3, 2025

AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions